FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Petition Against BDs Breast Reconstruction Device

A former Becton Dickinson medical director petitions FDA to scrutinize the companys 2017 510(k) clearance for the GalaForm 3D due to label misreprese...

latest-news-card-1
Human Drugs

FDA Webinar on ICH Bioequivalence Guidance

FDA announces a 5/2 Webcast entitled Navigating the First ICH Generic Drug Draft Guideline M13A Bioequivalence for Immediate-Release Solid Oral Dosag...

latest-news-card-1
Human Drugs

CGMP Violations at Formology Lab

FDA warns Chatsworth, CA-based Formology Lab about CGMP violations in its production of drugs as a contract manufacturer.

latest-news-card-1
Human Drugs

Objectionable Conditions at Avanti Study Site: FDA

FDA warns Houston, TX- based Dr. Maggie Jeffries/Avanti Anesthesiology about conducting a clinical investigation without a required IND.

latest-news-card-1
Federal Register

Guide on Gastric pH-Dependent Drug Interactions

Federal Register notice: FDA makes available a final guidance for industry entitled Evaluation of Gastric pH-Dependent Drug Interactions with Acid-Red...

latest-news-card-1
Federal Register

FDA Revokes 2 EUAs for Covid Tests

Federal Register notice: FDA revokes the Emergency Use Authorizations for Covid-issued to Abbott Diagnostics and Standard BioTools for their Covid-19 ...

Biologics

FDA Authorizes Pfizer Bivalent Vaccine for Young Children

FDA amends the emergency use authorization for the Pfizer-BioNTech Covid-19 bivalent vaccine and its use as a single booster dose to include children ...

latest-news-card-1
Human Drugs

FDA Clinical Hold on Mersana Tumor Drug

FDA places a clinical hold on Mersana Therapeutics Phase 1 trial of XMT-2056 after the company suspended it due to a recent patient death that was dee...

latest-news-card-1
Human Drugs

Guide on Gastric pH-Dependent Drug Interactions

FDA posts a final guidance entitled Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and C...

latest-news-card-1
Federal Register

Panel Set to review Intercept Pharma NASH Drug

Federal Register notice: FDA announces a 5/19 advisory committee meeting to discuss an Intercept Pharmaceuticals NDA for to nonalcoholic steatohepatit...